Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
171 Ergebnisse
| BD1GK6 |  | Vertex Pharmaceuticals Inc./KO/Call [endlos]/VONT | - | - | call | Vertex Pharmaceuticals Inc. | 478,890 | 478,890 | - | -0,321 % | - | Vontobel | |
| BD1L41 | | Vertex Pharmaceuticals Inc./KO/Put [endlos]/VONT | - | - | put | Vertex Pharmaceuticals Inc. | 479,550 | 479,550 | - | 0,459 % | - | Vontobel | |
| BD1RRU | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/VONT | - | - | call | Vertex Pharmaceuticals Inc. | 466,890 | 466,890 | - | 2,193 % | - | Vontobel | |
| BD1WNC | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/VONT | - | - | call | Vertex Pharmaceuticals Inc. | 479,080 | 479,080 | - | -0,360 % | - | Vontobel | |
| HC3NX2 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 337,633 | 337,633 | 3,355 | 29,271 % | - | Unicredit | |
| HC3NX3 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 351,138 | 351,138 | 3,697 | 26,442 % | - | Unicredit | |
| HC3NX4 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 364,643 | 364,643 | 4,125 | 23,613 % | - | Unicredit | |
| HC3NX5 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 378,149 | 378,149 | 4,665 | 20,783 % | - | Unicredit | |
| HC41QC | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 296,356 | 296,356 | 2,617 | 37,918 % | - | Unicredit | |
| HC41QD | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 309,827 | 309,827 | 2,814 | 35,096 % | - | Unicredit | |
| HC41QE | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 323,298 | 323,298 | 3,083 | 32,274 % | - | Unicredit | |
| HC59QY | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 386,991 | 386,991 | 5,116 | 18,931 % | - | Unicredit | |
| HD33L1 | | Vertex Pharmaceuticals Inc./Faktor/Long [2]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 236,545 | 236,545 | 1,983 | 50,447 % | - | Unicredit | |
| HD33L2 | | Vertex Pharmaceuticals Inc./Faktor/Long [3]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 315,393 | 315,393 | 2,984 | 33,930 % | - | Unicredit | |
| HD33L3 | | Vertex Pharmaceuticals Inc./Faktor/Long [4]/UniCredit | - | - | call | Vertex Pharmaceuticals Inc. | 354,818 | 354,818 | 4,004 | 25,671 % | - | Unicredit | |
| HD33LD | | Vertex Pharmaceuticals Inc./Faktor/Short [2]/UniCredit | - | - | put | Vertex Pharmaceuticals Inc. | 709,635 | 709,635 | 1,953 | 48,658 % | - | Unicredit | |
| HD33LE | | Vertex Pharmaceuticals Inc./Faktor/Short [3]/UniCredit | - | - | put | Vertex Pharmaceuticals Inc. | 630,787 | 630,787 | 2,958 | 32,141 % | - | Unicredit | |
| HD33LF | | Vertex Pharmaceuticals Inc./Faktor/Short [4]/UniCredit | - | - | put | Vertex Pharmaceuticals Inc. | 591,363 | 591,363 | 3,925 | 23,882 % | - | Unicredit | |
| MB7K7M | | Vertex Pharmaceuticals Inc./Faktor/Long [3]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 315,451 | 331,230 | 3,011 | 30,612 % | - | Morgan Stanley | |
| MC1UYN | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 189,591 | 189,591 | 1,646 | 60,283 % | - | Morgan Stanley | |
| MC4JT8 | | Vertex Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 354,873 | 372,620 | 4,024 | 21,942 % | - | Morgan Stanley | |
| MD33DU | | Vertex Pharmaceuticals Inc./Faktor/Short [4]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 591,373 | 561,800 | - | 17,689 % | - | Morgan Stanley | |
| MD3AM6 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 336,855 | 336,855 | 3,351 | 29,434 % | - | Morgan Stanley | |
| MD5HWD | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 332,678 | 375,420 | 3,250 | 21,355 % | - | Morgan Stanley | |
| MD7Y8L | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 356,595 | 356,595 | 3,863 | 25,298 % | - | Morgan Stanley | |
| MG27HQ | | Vertex Pharmaceuticals Inc./Faktor/Long [2]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 236,598 | 248,430 | 2,015 | 47,958 % | - | Morgan Stanley | |
| MG2KV8 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 321,908 | 321,908 | 3,022 | 32,565 % | - | Morgan Stanley | |
| MG8E95 | | Vertex Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 596,517 | 596,517 | 4,038 | 24,962 % | - | Morgan Stanley | |
| MJ42ER | | Vertex Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 378,557 | 397,490 | 5,027 | 16,732 % | - | Morgan Stanley | |
| MJ6HVZ | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 305,577 | 344,840 | 2,741 | 27,761 % | - | Morgan Stanley | |
| MK6YBX | | Vertex Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 394,331 | 414,050 | 6,041 | 13,263 % | - | Morgan Stanley | |
| MK944K | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 329,076 | 329,076 | 3,172 | 31,063 % | - | Morgan Stanley | |
| MM0X2T | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 370,394 | 370,394 | 4,338 | 22,408 % | - | Morgan Stanley | |
| MM1KV0 | | Vertex Pharmaceuticals Inc./Faktor/Short [6]/MS | - | - | put | Vertex Pharmaceuticals Inc. | 551,925 | 524,320 | 5,755 | 9,837 % | - | Morgan Stanley | |
| MM20ED | | Vertex Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 354,898 | 372,650 | 4,075 | 21,935 % | - | Morgan Stanley | |
| MM20EE | | Vertex Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 378,557 | 397,490 | 5,120 | 16,732 % | - | Morgan Stanley | |
| MM20EF | | Vertex Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 394,331 | 414,050 | 6,112 | 13,263 % | - | Morgan Stanley | |
| MM20EG | | Vertex Pharmaceuticals Inc./Faktor/Long [8]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 414,047 | 434,750 | - | 8,926 % | - | Morgan Stanley | |
| MM20EH | | Vertex Pharmaceuticals Inc./Faktor/Long [10]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 425,877 | 447,180 | - | 6,322 % | - | Morgan Stanley | |
| MM2MHC | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 400,043 | 400,043 | 5,900 | 16,197 % | - | Morgan Stanley | |
| MM2MMQ | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 191,362 | 216,100 | 1,664 | 54,730 % | - | Morgan Stanley | |
| MM2MMR | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 229,790 | 259,320 | 1,913 | 45,676 % | - | Morgan Stanley | |
| MM2MMS | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 248,940 | 280,930 | 2,073 | 41,149 % | - | Morgan Stanley | |
| MM2MMT | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 287,043 | 324,150 | 2,483 | 32,095 % | - | Morgan Stanley | |
| MM2MMU | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 315,962 | 356,560 | 2,913 | 25,306 % | - | Morgan Stanley | |
| MM2MMV | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 325,536 | 367,360 | 3,096 | 23,043 % | - | Morgan Stanley | |
| MM2MMW | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 344,686 | 388,970 | 3,536 | 18,516 % | - | Morgan Stanley | |
| MM2MMX | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 354,260 | 399,780 | 3,798 | 16,252 % | - | Morgan Stanley | |
| MM4DG0 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 294,073 | 332,080 | 2,576 | 30,434 % | - | Morgan Stanley | |
| MM4TW3 | | Vertex Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Vertex Pharmaceuticals Inc. | 360,114 | 406,380 | 3,979 | 14,869 % | - | Morgan Stanley |